
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 169167
[patent_doc_number] => 07667071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Process for the preparation of gabapentin hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 11/990681
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4439
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/667/07667071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990681
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990681 | Process for the preparation of gabapentin hydrochloride | Apr 27, 2006 | Issued |
Array
(
[id] => 5705779
[patent_doc_number] => 20060194827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => '5-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds'
[patent_app_type] => utility
[patent_app_number] => 11/411676
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19284
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194827.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411676 | 5-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds | Apr 24, 2006 | Abandoned |
Array
(
[id] => 4995207
[patent_doc_number] => 20070010552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Fluorinated heterocyclic compounds and methods of synthesis'
[patent_app_type] => utility
[patent_app_number] => 11/410357
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6539
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010552.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410357 | Fluorinated heterocyclic compounds and methods of synthesis | Apr 24, 2006 | Abandoned |
Array
(
[id] => 5678549
[patent_doc_number] => 20060183905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'DERIVATIVES OF 4-(THIO-OR SELENOXANTHENE-9-YLIDENE)-PIPERIDINE OR ACRIDINE AND ITS USE AS A SELECTIVE 5-HT2B RECEPTOR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 11/379353
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10728
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183905.pdf
[firstpage_image] =>[orig_patent_app_number] => 11379353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/379353 | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist | Apr 18, 2006 | Issued |
Array
(
[id] => 4445408
[patent_doc_number] => 07863447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Diphosphines and metal complexes'
[patent_app_type] => utility
[patent_app_number] => 11/887448
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10380
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/863/07863447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11887448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887448 | Diphosphines and metal complexes | Apr 18, 2006 | Issued |
Array
(
[id] => 5851848
[patent_doc_number] => 20060235039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Hydromorphone polymorphs'
[patent_app_type] => utility
[patent_app_number] => 11/405286
[patent_app_country] => US
[patent_app_date] => 2006-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4058
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405286
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405286 | Hydromorphone polymorphs | Apr 16, 2006 | Issued |
Array
(
[id] => 5662162
[patent_doc_number] => 20060252758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Spiroheterocyclic compounds and their uses as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/402200
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32857
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402200 | Spiroheterocyclic compounds and their uses as therapeutic agents | Apr 10, 2006 | Issued |
Array
(
[id] => 131964
[patent_doc_number] => 07700641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Spiro-oxindole compounds and their uses as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/402310
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144383
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700641.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402310 | Spiro-oxindole compounds and their uses as therapeutic agents | Apr 10, 2006 | Issued |
Array
(
[id] => 583334
[patent_doc_number] => 07449490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Pharmaceutically active compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/402240
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32558
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402240 | Pharmaceutically active compounds and methods of use | Apr 10, 2006 | Issued |
Array
(
[id] => 10870544
[patent_doc_number] => 08895742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Metal-mediated reversible self-assembly of carbon nanotubes'
[patent_app_type] => utility
[patent_app_number] => 11/910772
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 19
[patent_no_of_words] => 4137
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910772
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910772 | Metal-mediated reversible self-assembly of carbon nanotubes | Apr 6, 2006 | Issued |
Array
(
[id] => 5324554
[patent_doc_number] => 20090062544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Crystals of Morphinan Derivative and Process for Producing the Same'
[patent_app_type] => utility
[patent_app_number] => 11/887842
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4473
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062544.pdf
[firstpage_image] =>[orig_patent_app_number] => 11887842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887842 | Crystals of morphinan derivative and process for producing the same | Apr 5, 2006 | Issued |
Array
(
[id] => 5673035
[patent_doc_number] => 20060178390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => '1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'
[patent_app_type] => utility
[patent_app_number] => 11/398239
[patent_app_country] => US
[patent_app_date] => 2006-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22412
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398239 | 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders | Apr 4, 2006 | Abandoned |
Array
(
[id] => 7691393
[patent_doc_number] => 20070232640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Antifungal and antiparasitic indoloquinoline derivates'
[patent_app_type] => utility
[patent_app_number] => 11/394158
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7748
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232640.pdf
[firstpage_image] =>[orig_patent_app_number] => 11394158
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/394158 | Antifungal and antiparasitic indoloquinoline derivates | Mar 30, 2006 | Issued |
Array
(
[id] => 5609179
[patent_doc_number] => 20060270695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Spirocyclic heterocyclic derivatives and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 11/393133
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 176966
[patent_no_of_claims] => 279
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393133 | Spirocyclic heterocyclic derivatives and methods of their use | Mar 29, 2006 | Issued |
Array
(
[id] => 5667679
[patent_doc_number] => 20060173029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone'
[patent_app_type] => utility
[patent_app_number] => 11/391897
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17661
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20060173029.pdf
[firstpage_image] =>[orig_patent_app_number] => 11391897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/391897 | Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone | Mar 28, 2006 | Abandoned |
Array
(
[id] => 5754659
[patent_doc_number] => 20060223808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Spirocyclic thrombin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/392324
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15136
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223808.pdf
[firstpage_image] =>[orig_patent_app_number] => 11392324
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/392324 | Spirocyclic thrombin receptor antagonists | Mar 28, 2006 | Issued |
Array
(
[id] => 486882
[patent_doc_number] => 07217822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-15
[patent_title] => 'Process for making cabergoline'
[patent_app_type] => utility
[patent_app_number] => 11/377397
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3157
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377397 | Process for making cabergoline | Mar 16, 2006 | Issued |
Array
(
[id] => 4728149
[patent_doc_number] => 20080207693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Mitotic Kinesin Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/886282
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25366
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886282 | Mitotic Kinesin Inhibitors | Mar 9, 2006 | Abandoned |
Array
(
[id] => 5172456
[patent_doc_number] => 20070072889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Hydrocodone polymorphs'
[patent_app_type] => utility
[patent_app_number] => 11/371377
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2699
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371377 | Hydrocodone polymorphs | Mar 7, 2006 | Issued |
Array
(
[id] => 5576224
[patent_doc_number] => 20090143586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Method for producing alkyl-substituted aromatic and heteroaromatic compounds by cross-coupling alkyl boronic acids with aryl-or heteroaryl-halogenides or sulfonates under Pd catalysis in the presence of a ligand'
[patent_app_type] => utility
[patent_app_number] => 11/817820
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3257
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143586.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817820 | Method for producing alkyl-substituted aromatic and heteroaromatic compounds by cross-coupling alkyl boronic acids with aryl-or heteroaryl-halogenides or sulfonates under Pd catalysis in the presence of a ligand | Mar 6, 2006 | Abandoned |